TradingView’s own chart and price feed. The page’s numbers are end-of-day closes.
Data provided by Databento (end of day). Next close = the first close after a story against the close before it; official daily closes only, not a call, not advice.
The numbers
fiscal 2025, as filed with the SEC · 66-metric EOD snapshot via Databento
Market cap$2.1B
EV / FCF103.8x
Revenue$305.1M +100.0%
True FCF (ex-SBC)$-201,000 +133.6%
Rule of 40105.2%
ROIC37.2%
True FCF Yield0.0%
EPS, diluted$0.14 +103.4%
Modern Valuation (EOD)
Market Cap$2.1B
Enterprise Value$1.6B
EV / True FCF—
EV / FCF103.81
EV / Gross Profit7.83
EV / EBIT101.81
EV / Sales5.35
P / E (GAAP)277.70
P / FCF131.73
P / Oper. CF84.16
P / Book4.31
Owner & Cash Yields
True FCF Yield0.0%
FCF Yield0.8%
Owner Earn. Yield-0.5%
Earnings Yield0.4%
Shareholder Yield−0.8%
Buyback Yield0.0%
Dividend Yield—
Dividend / sh—
Payout Ratio—
FCF / sh—
EPS (diluted)$0.14
Compounder & Returns
Rule of 40105.2%
ROIC37.2%
Cash ROIC (CROIC)38.0%
GP / Assets32.9%
ROE1.6%
ROA1.2%
Gross Margin68.3%
Oper. Margin5.3%
Net Margin2.4%
FCF Margin5.2%
True FCF Margin-0.1%
Quality & Dilution
Cash Conversion211%
Accrual Ratio−2.7%
SBC % of FCF101.3%
SBC % of Rev5.2%
Reinvest. Rate237%
Sales Growth Y/Y+100.0%
Sales 3Y CAGR—
EPS Growth Y/Y+103.4%
FCF Growth Y/Y+133.6%
FCF 3Y CAGR—
Share Change Y/Y+110.6%
Balance Sheet & Scale
Revenue (FY)$305.1M
Gross Profit (FY)$208.5M
Oper. Income (FY)$16.0M
GAAP Net Income$7.5M
True FCF (ex-SBC)$-201,000
Cash & Equiv$496.0M
Total Debt$57.2M
Net Cash (Debt)$438.7M
Net Cash % MCap+21.2%
Debt / FCF (yrs)3.6y
Current Ratio11.69
Price & Technicals (EOD)
Perf Week−18.58%
Perf Month−13.82%
Perf Quarter−5.08%
Perf Half Y+4.70%
Perf YTD+25.07%
SMA 20 Dist−16.68%$108.26
SMA 50 Dist−15.37%$106.58
SMA 100 Dist−17.66%$109.55
Window High−39.85%$149.97
Window Low+25.07%$72.12
RSI (14) · Vol30.350%v
Income Distribution & Cash Flow ConversionHow every dollar of BLLN revenue flows through cost of goods, operating expenses, taxes, GAAP net income, and dilution-adjusted free cash flow
Less: Stock-Based Comp (SBC)−$15.9M(101.3% of FCF)
True FCF (Owner Cash ex-SBC)$-201,000(-0.1% of rev)
Revenue by fiscal year
$71.7MFY23
$152.6MFY24
$305.1MFY25
Operating leverage — margins
GrossOperatingNet
Unlocked SEC EDGAR Accounting Statements (USD)All 3 statements · Common-size (% of Revenue / Assets) · YoY growth · Tap any core row to explain
Line Item (USD)
FY2023
FY2024
FY2025
YoY Δ
CAGR
Trend
Income Statement
Revenue ▸
$71.7M
$152.6M
$305.1M
+100.0%
+106.2%
Cost of Revenue (COGS)
$54.4M
$71.7M
$96.7M
+34.9%
+33.3%
Gross Profit ▸
$17.3M
$80.9M
$208.5M
+157.6%
+247.0%
Research & Development (R&D)
$22.4M
$36.6M
$49.4M
+34.9%
+48.4%
Selling, General & Admin (SG&A)
$64.4M
$91.5M
$143.1M
+56.4%
+49.1%
Total Operating Expenses
$86.8M
$128.1M
$192.4M
+50.3%
+48.9%
Operating Income (EBIT) ▸
$-69.5M
$-47.1M
$16.0M
+134.0%
—
Interest Expense
$3.3M
$2.4M
$95,000
−96.0%
−83.0%
Income Tax Expense
$9,000
$29,000
$305,000
+951.7%
+482.1%
GAAP Net Income ▸
$-82.7M
$-41.6M
$7.5M
+117.9%
—
Diluted EPS ▸
$-8.45
$-4.12
$0.14
+103.4%
—
Diluted Shares
9.8M
10.1M
21.2M
+110.6%
+47.3%
Balance Sheet
Cash & Equivalents
$97.3M
$191.5M
$496.0M
+159.0%
+125.8%
Inventory
$21.9M
$8.7M
$17.5M
+100.9%
−10.5%
Total Current Assets
$682.1M
$227.8M
$560.6M
+146.1%
−9.3%
Total Assets
$760.5M
$302.1M
$632.7M
+109.4%
−8.8%
Total Current Liabilities
$60.6M
$28.4M
$48.0M
+69.0%
−11.1%
Total Debt (Short + Long Term)
$89.0M
$51.5M
$57.2M
+11.2%
−19.8%
Total Liabilities
$193.9M
$134.3M
$152.5M
+13.6%
−11.3%
Stockholders' Equity
$-219.1M
$-251.7M
$480.1M
+290.8%
—
Net Cash / (Net Debt)
$8.3M
$140.0M
$438.7M
+213.4%
+627.7%
Invested Capital
$-227.3M
$-391.7M
$41.4M
+110.6%
—
Cash Flow & Capital Allocation
Operating Cash Flow (OCF) ▸
$-53.7M
$-41.4M
$24.6M
+159.4%
—
Depreciation & Amortization (D&A)
$5.9M
$7.0M
$6.9M
−1.4%
+8.1%
Stock-Based Compensation (SBC)
$4.9M
$8.4M
$15.9M
+90.3%
+81.1%
Capital Expenditures (CapEx)
$6.2M
$5.4M
$8.9M
+64.4%
+19.9%
Free Cash Flow (FCF) ▸
$-59.8M
$-46.8M
$15.7M
+133.6%
—
True FCF (ex-SBC Owner Cash)
$-64.7M
$-55.1M
$-201,000
+99.6%
—
Share Repurchases (Buybacks)
$0
$546,000
$0
−100.0%
—
Fundamentals, income distribution and multi-year statements from SEC EDGAR filings (public domain). Valuation multiples, performance and technicals computed from Databento 1D EOD closes. For information only, not investment advice.
On the Wire
what BLLN did at the next close after each story
No Wire story has named BLLN yet.
The Wire at 7 AM ET, free. Top stories with a bull and a bear case on each, every morning. No account needed.
What happened · big days
19 big days in a year, and what we hold on each
A big day is a close more than 9.05% from the one before, three times BLLN’s median day (3.02%). On 0 of the 19, its peer group moved the same way at least half as far. We show what we hold. We never name a cause.
every other trading daya big day, numbered in the list below±9.05%Hover a bar for its day. Click a big day to open it.
Shaded: since our stories began, Jun 10. Tap a bar for its day.
#DayBLLNWhat we hold that dayGroup (median of 4) · each
1 Nov 21, 2025+14.97%
Before our storiesgroup +2.1%, did not move with it
1Nov 21, 2025+14.97%
Before our stories
+2.1% did not move with itGH +5.1 · NTRA +2.3 · DGX +1.9 · LH +1.6
2 Dec 1, 2025−13.17%
Before our storiesgroup −2.4%, did not move with it
2Dec 1, 2025−13.17%
Before our stories
−2.4% did not move with itGH −3.0 · DGX −2.9 · NTRA −1.9 · LH −0.4
3 Dec 3, 2025−10.58%
Before our storiesgroup +0.3%, did not move with it
3Dec 3, 2025−10.58%
Before our stories
+0.3% did not move with itLH −0.1 · DGX +0.0 · NTRA +0.7 · GH +2.0
4 Dec 23, 2025−9.57%
Before our storiesgroup −0.4%, did not move with it
4Dec 23, 2025−9.57%
Before our stories
−0.4% did not move with itLH −0.8 · DGX −0.7 · NTRA −0.1 · GH +1.1
5 Jan 2, 2026+9.10%
Before our storiesgroup +0.0%, did not move with it
5Jan 2, 2026+9.10%
Before our stories
+0.0% did not move with itLH +0.3 · DGX +0.1 · NTRA −0.1 · GH −0.4
6 Jan 12, 2026+15.37%
Resultsgroup −0.0%, did not move with it
6Jan 12, 2026+15.37%
ResultsFirst close after the Jan 12 results filing
−0.0% did not move with itDGX +0.9 · NTRA +0.5 · LH −0.6 · GH −2.4
7 Feb 23, 2026−15.59%
Before our storiesgroup −0.2%, did not move with it
7Feb 23, 2026−15.59%
Before our stories
−0.2% did not move with itGH −8.4 · NTRA −1.3 · LH +0.9 · DGX +2.5
8 Mar 5, 2026−10.71%
Resultsgroup −1.9%, did not move with it
8Mar 5, 2026−10.71%
ResultsFirst close after the Mar 4 results filing
−1.9% did not move with itNTRA −2.9 · DGX −2.1 · LH −1.8 · GH −0.5
9 Mar 31, 2026+12.59%
Before our storiesgroup +4.1%, did not move with it
9Mar 31, 2026+12.59%
Before our stories
+4.1% did not move with itGH +7.2 · NTRA +7.0 · LH +1.2 · DGX −0.6
10 Apr 9, 2026−10.31%
Before our storiesgroup −2.1%, did not move with it
10Apr 9, 2026−10.31%
Before our stories
−2.1% did not move with itGH −6.1 · NTRA −3.7 · LH −0.5 · DGX −0.5
11 Apr 20, 2026+9.49%
Before our storiesgroup +0.2%, did not move with it
11Apr 20, 2026+9.49%
Before our stories
+0.2% did not move with itGH +0.8 · DGX +0.7 · NTRA −0.3 · LH −0.6
12 May 5, 2026+10.79%
Before our storiesgroup −1.1%, did not move with it
12May 5, 2026+10.79%
Before our stories
−1.1% did not move with itLH +1.6 · DGX −0.3 · GH −1.8 · NTRA −2.3
13 May 7, 2026+14.13%
Resultsgroup +0.7%, did not move with it
13May 7, 2026+14.13%
ResultsFirst close after the May 6 results filing
+0.7% did not move with itNTRA +2.2 · DGX +0.9 · LH +0.4 · GH +0.0
14 May 11, 2026+13.96%
Before our storiesgroup +1.2%, did not move with it
14May 11, 2026+13.96%
Before our stories
+1.2% did not move with itNTRA +2.5 · DGX +1.3 · GH +1.1 · LH +0.4
15 May 12, 2026−11.05%
Before our storiesgroup +1.7%, did not move with it
15May 12, 2026−11.05%
Before our stories
+1.7% did not move with itDGX +0.2 · LH +0.9 · NTRA +2.5 · GH +3.3
16 Aug 6, 2026−38.89%
Resultsgroup −1.3%, did not move with it
16Aug 6, 2026−38.89%
ResultsFirst close after the Aug 5 results filing
−1.3% did not move with itGH −3.4 · NTRA −3.4 · LH +0.8 · DGX +1.1
17 Sep 22, 2026+11.76%
Nothing on BLLNgroup −0.5%, did not move with it
17Sep 22, 2026+11.76%
Nothing on BLLNNo BLLN story, brief or results filing in our record that day
−0.5% did not move with itNTRA +5.5 · GH +1.9 · LH −2.9 · DGX −4.1
18 Sep 24, 2026+9.16%
Nothing on BLLNgroup +1.6%, did not move with it
18Sep 24, 2026+9.16%
Nothing on BLLNNo BLLN story, brief or results filing in our record that day
+1.6% did not move with itNTRA +4.6 · LH +1.6 · DGX +1.5 · GH +0.1
19 Sep 30, 2026−9.93%
Nothing on BLLNgroup +0.1%, did not move with it
19Sep 30, 2026−9.93%
Nothing on BLLNNo BLLN story, brief or results filing in our record that day
+0.1% did not move with itNTRA −0.3 · LH −0.2 · GH +0.3 · DGX +0.5
A story on the same day is not a cause, and a group move is not proof either. Group: the median of NTRA, LH, DGX and GH that day, the largest companies in BLLN’s SEC industry; “moved with BLLN” means the same direction and at least half the size.
What’s next · results
Before the next report: what the first day after the last four did
Six trading days after each results filing (SEC 8-K, Item 2.02). BLLN reports after the close, so day 1 is the next close. Each time, day 6 ended on the same side as day 1.
Reported Mar 4, 2026
day 1−10.71%day 6−20.78%
Reported May 6, 2026
day 1+14.13%day 6+8.03%
Reported Aug 5, 2026
day 1−38.89%day 6−37.29%
Reported Nov 4, 2026
day 1−1.32%day 6−2.72%
Next report: expected early FebruaryEstimated from the dates of its last four results filings. Not announced. Since the Nov 4 report: −19.62%. Four reports is a small sample.
Each line is BLLN’s close against its close before the filing, on licensed end-of-day closes. What happened after each report, not a forecast; a move on the day is not a cause.
Same industry
BLLN against four same-industry peers, a year at 100
BLLN is down 16.8% in a year. Labcorp Holdings is up 39.6%, Guardant Health 37.7%, Quest Diagnostics 35.8% and Natera 25.5%. All four did more. Weekly closes, Nov 21, 2025 = 100, on a log scale, so the same percentage move is the same height on every line.
End-of-day closes (Databento EOD), the last close of each week. The four peers are the largest US-listed companies by market value in BLLN’s SEC industry (Services-Medical Laboratories) with a year of closes. It shows what the closes did; a move here is not a cause, a forecast or a call.